Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinoma

Published:2023-04-30 Issue:6 Volume:97 Page:1627-1647
ISSN:0340-5761
Container-title:Archives of Toxicology
language:en
Short-container-title:Arch Toxicol

Author:

Lin Xian,Chen Jian,Li Xin,Chen Dong,Luo Kaixuan,Deng Yongxing,Yang Dinghua,Huang Zunnan,Tao Cheng^ORCID

Funder

China Postdoctoral Science Foundation

Guangdong Basic and Applied Basic Research Foundation

Key Discipline Construction Project of Guangdong Medical University

Medical Scientific Research Foundation of Guangdong Province, China

Dongguan Social science and Technology Development (Key) Project

Funds for PHD researchers of Guangdong Medical University in 2022

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00204-023-03501-8.pdf

Reference55 articles.

1. Albring KF, Weidemuller J, Mittag S et al (2013) Berberine acts as a natural inhibitor of Wnt/beta-catenin signaling–identification of more active 13-arylalkyl derivatives. BioFactors 39(6):652–662. https://doi.org/10.1002/biof.1133

2. Angers S (2021) Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors. EMBO Mol Med 13(4):e14002. https://doi.org/10.15252/emmm.202114002

3. Anwar MA, Tabassam S, Gulfraz M, Sheeraz Ahmad M, Raja GK, Arshad M (2020) Isolation of oxyberberine and beta-sitosterol from berberis lycium royle root bark extract and in vitro cytotoxicity against liver and lung cancer cell lines. Evid Based Complement Alternat Med 2020:2596082. https://doi.org/10.1155/2020/2596082

4. Arita J, Ichida A, Nagata R et al (2022) Conversion surgery after preoperative therapy for advanced hepatocellular carcinoma in the era of molecular targeted therapy and immune checkpoint inhibitors. J Hepatobiliary Pancreat Sci 29(7):732–740. https://doi.org/10.1002/jhbp.1135

5. Burdak-Rothkamm S, Rothkamm K (2021) DNA damage repair deficiency and synthetic lethality for cancer treatment. Trends Mol Med 27(1):91–92. https://doi.org/10.1016/j.molmed.2020.09.011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. pH-responsive berberine release from metal-organic framework based nanocarriers by regulating oxidative stress for targeted therapy of oral squamous cell carcinoma;Arabian Journal of Chemistry;2024-09

2. Liensinine diperchlorate and artemisitene synergistically attenuate breast cancer progression through suppressing PI3K-AKT signaling and their efficiency in breast cancer patient-derived organoids;Biomedicine & Pharmacotherapy;2024-07

3. Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling;Cellular & Molecular Biology Letters;2024-05-02

4. Sesamol serves as a p53 stabilizer to relieve rheumatoid arthritis progression and inhibits the growth of synovial organoids;Phytomedicine;2023-12

5. Phellopterin attenuates ovarian cancer proliferation and chemoresistance by inhibiting the PU.1/CLEC5A/PI3K-AKT feedback loop;Toxicology and Applied Pharmacology;2023-10